Investment – Divestment
2006 – …
Turnover
€475M
- Unither is one of the world’s leading manufacturers of niche dosage forms for pharmaceutical companies and the world leader in blow-fill-seal (BFS) technology.
- Parquest invested in Unither as part of a secondary MBO alongside the management team.
- Since its creation, the group has pursued a development strategy aimed at strengthening its leadership and international presence through internal and external growth. It currently operates 5 plants in France, the US, Brazil and China and 1 R&D center.
- Parquest has been supporting the management team since 2006: as a majority shareholder from 2006 to 2011 and as a minority shareholder since then through successive MBO operations alongside Eric Goupil and his team. In early 2023, Parquest reinvested in Unither as part of a consortium of funds, including GIC, IK and Keensight.
